Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants

Official title

Utilizing Spheres of Influence to Increase Cancer Screening: Empowering Community Health Advocates

Overview

This clinical trial assesses the use of advocates and supporters of breast and lung cancer screening to increase lung cancer screening rates amongst eligible participants. Imaging-based cancer screening is utilized with variable frequency. Breast cancer screening with mammography has been widely accepted and is commonly used among eligible women. Lung screening with computed tomography scans is poorly used, despite the potential to decrease deaths from lung cancer. There are many reasons lung screening isn't being used when compared to breast screening, such as smoking stigma and fear, along with a lack of awareness of lung screening. By conducting this trial, researchers want to assess the effectiveness of advocates and supporters of breast and lung screening, and to learn about the psychological barriers to cancer screening, identifying those that are unique to lung screening.

Detailed description

PRIMARY OBJECTIVES:

I. Determine the number of patients undergoing breast screening who are eligible to participate in lung screening.

II. Determine whether patients currently participating in cancer screening (breast OR lung) are successful as "cancer screening advocates." III. Determine whether laypersons who are aware of screening (including those who accompany friends and family members to their screening appointments) are successful as "cancer screening advocates." IV. Identify knowledge base and psychological barriers to screening through surveys of potential screening participants.

OUTLINE:

Participants access an electronic patient portal with educational materials at baseline, 1- and 2-year follow-ups, and also interact with a patient navigator on study. Patients also receive materials to share with their friends/family on benefits of breast and lung cancer screening on study.

After completion of study intervention, participants are followed up yearly for up to 3 years.

Interventions

• Behavioral Health Education
  Access electronic patient portal with educational material
• Other Health Promotion and Education
  Receive materials on breast/lung cancer screening
• Behavioral Patient Navigation
  Interact with a patient navigator
• Other Survey Administration
  Ancillary studies

Primary outcome measures

• Increased rates of lung and breast cancer screening adherence [Time frame: Up to 3 years]

Secondary outcome measures (1)

• Success of "sphere of influence" model [Time frame: Up to 3 years]

Eligibility criteria

Inclusion criteria

• Age:

• Breast screening > 40
• Lung screening 50-80
• Male (M) or Female (F)
• Current, former, or never smokers
• Close family or friend with smoking history (in or out of state)

Exclusion criteria

• Age:

• Breast screening < 40
• Lung screening < 50 or > 80
• Persons who had previously received a diagnosis of lung cancer, had hemoptysis, or had an unexplained weight loss of more than 6.8 kg (15 lb) in the preceding year will also be excluded
• Persons with an active cancer

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation

N/A

Model

Single group

Masking

Open label

Primary purpose

Screening

Study locations

United States · 1 center

• UCLA / Jonsson Comprehensive Cancer Center — Los Angeles

Identifiers

NCT: NCT05978128 · 22-000947 · NCI-2023-04133

Primary sources (government registries)

• ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗